Jazz Pharmaceuticals (JAZZ) Cash from Operations (2010 - 2026)

Jazz Pharmaceuticals' Cash from Operations history runs 17 years deep, the most recent figure standing at 408200000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 5.03% year-over-year to 408200000.0 in Q1 2026; TTM through Mar 2026 was 1334173000.0, a 14.39% decrease from a year earlier, with the FY2025 full-year figure at 1355773000.0, down 2.88% from the prior year.
• Cash from Operations rose to 408200000.0 in Q1 2026 per JAZZ's latest filing, from 362518000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 474616000.0 in Q3 2025 and bottomed at 88839000.0 in Q2 2025.
• The 5-year median for Cash from Operations is 331352000.0 (2024), against an average of 324933235.29.
• Across the five-year window, Cash from Operations jumped 626.79% in 2022 and sank 73.19% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 341971000.0 in 2022, then sank by 51.07% to 167339000.0 in 2023, then soared by 138.19% to 398580000.0 in 2024, then declined by 9.05% to 362518000.0 in 2025, then advanced by 12.6% to 408200000.0 in 2026.
• Per Business Quant, the three latest JAZZ Cash from Operations figures stand at 408200000.0 (Q1 2026), 362518000.0 (Q4 2025), and 474616000.0 (Q3 2025).